Table 3.
Association of LHR-P with demographics and disease characteristics
| Factors | Na | LHR Expression Observed in Tumor Cells | p-value* | |
|---|---|---|---|---|
| ≤ 50% | > 50% | |||
| Age at Diagnosis | ||||
| < 60 | 130 | 24 (18%) | 106 (82%) | 0.09 |
| ≥ 60 | 101 | 10 (10%) | 91 (90%) | |
| Histology | ||||
| Serous | 159 | 19 (12%) | 140 (68%) | 0.11 |
| Other | 72 | 15 (21%) | 57 (79%) | |
| Pathologic Stage | ||||
| I/II | 68 | 15 (22%) | 53 (78%) | 0.065 |
| III/IV | 163 | 19 (12%) | 144 (88%) | |
| Silberberg’s Grade | ||||
| 1 | 27 | 8 (30%) | 19 (70%) | 0.037 |
| 2 or 3 | 204 | 26 (13%) | 178 (87%) | |
| Persistent Disease | ||||
| No | 143 | 25 (17%) | 118 (83%) | 0.18 |
| Yes | 88 | 9 (10%) | 79 (90%) | |
aone patient doesn’t have LHR expression observed in tumor cell data available
*p-value based on Fisher’s exact test